Thomas White International’s Jazz Pharmaceuticals JAZZ Stock Holding History

Thomas White International’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,270	Closed	-$127K	–	294
2020 Q1	$127K	Sell	1,270 -2,030	-62%	-$262K	0.03%	253
2019 Q4	$493K	Hold	3,300	–	–	0.08%	215
2019 Q3	$423K	Hold	3,300	–	–	0.08%	209
2019 Q2	$470K	Hold	3,300	–	–	0.08%	200
2019 Q1	$472K	Hold	3,300	–	–	0.09%	199
2018 Q4	$409K	Sell	3,300 -1,000	-23%	-$148K	0.08%	195
2018 Q3	$723K	Hold	4,300	–	–	0.12%	170
2018 Q2	$741K	Hold	4,300	–	–	0.12%	164
2018 Q1	$649K	Hold	4,300	–	–	0.11%	166
2017 Q4	$579K	Hold	4,300	–	–	0.1%	174
2017 Q3	$629K	Hold	4,300	–	–	0.11%	171
2017 Q2	$669K	Hold	4,300	–	–	0.12%	172
2017 Q1	$624K	Hold	4,300	–	–	0.09%	178
2016 Q4	$469K	Hold	4,300	–	–	0.07%	182
2016 Q3	$522K	Buy	4,300 +1,800	+72%	+$243K	0.07%	168
2016 Q2	$353K	Hold	2,500	–	–	0.05%	176
2016 Q1	$326K	Hold	2,500	–	–	0.05%	178
2015 Q4	$351K	Hold	2,500	–	–	0.05%	187
2015 Q3	$332K	Hold	2,500	–	–	0.05%	201
2015 Q2	$440K	Hold	2,500	–	–	0.06%	181
2015 Q1	$432K	Hold	2,500	–	–	0.06%	181
2014 Q4	$409K	Hold	2,500	–	–	0.06%	185
2014 Q3	$401K	Hold	2,500	–	–	0.06%	187
2014 Q2	$368K	Buy	+2,500	New	+$347K	0.05%	201

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Thomas White International's JAZZ Position: Q2 2020 in Review

Thomas White International sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2020, closing a stake of 1,270 shares — an estimated $127K sold.

Thomas White International first reported a position in JAZZ in Q2 2014 and held it in 24 quarters. The position peaked at $741K in Q2 2018. 384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

Thomas White International reported no remaining Jazz Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Thomas White International sold 1,270 Jazz Pharmaceuticals shares in Q2 2020, an estimated $127K.
Thomas White International first reported a position in Jazz Pharmaceuticals in Q2 2014 and held it in 24 quarters.
Thomas White International's Jazz Pharmaceuticals position peaked at $741K in Q2 2018.
384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Thomas White International's 13F filing for Q2 2020, filed 12 Aug 2020.